Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN101508741B details a green synthesis route for Methylated-β-cyclodextrin using dimethyl carbonate, offering safer supply chains and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN107653238A reveals immobilized carbonyl reductase cells for high-yield statin intermediate production, offering significant supply chain stability and cost reduction advantages.
Patent CN104059026B reveals a one-pot Dimroth rearrangement for Erlotinib Hydrochloride, offering high purity and scalable manufacturing for reliable pharmaceutical intermediate supply chains.
Patent CN108059601A reveals high-yield synthesis for vildagliptin intermediate. Discover cost reduction in API intermediate manufacturing and supply chain reliability.
Patent CN109180628A details eco-friendly apiolin synthesis. This method ensures high purity and supply chain stability for global pharmaceutical manufacturers seeking cost reduction.
Patent CN115991705A discloses novel CDK8 inhibitors with potent anti-tumor activity. Discover the scalable Suzuki-Miyaura synthesis route and supply chain advantages.
Patent CN110218229B reveals a mild copper-catalyzed route for beta-mercapto azaphospho derivatives, offering safer manufacturing and cost reduction for pharmaceutical intermediates.
Patent CN118164963A reveals a novel imine reduction route for Lynacarv. Achieves >99% ee value with reduced cost and enhanced supply chain reliability for global buyers.
Patent CN121250383A reveals metal-free electrochemical route. Enhances purity and reduces waste for scalable pharmaceutical intermediates manufacturing supply chains.
Patent CN101575286B details a novel route for simvastatin ammonium salt, offering higher purity and yield for API manufacturing supply chains.
Patent CN103724250B details a novel S-Oxiracetam synthesis. Achieves high purity and yield with cost-effective, scalable industrial processes for global supply chains.
Patent CN103073443B details a novel asymmetric synthesis for Pregabalin, offering improved yield and scalability for pharmaceutical supply chains.
Patent CN111646994A reveals a novel acylation route for guanine intermediates, offering significant cost reduction and supply chain reliability for antiviral drug manufacturers.
Patent CN100383143C details a one-pot rifampicin synthesis eliminating intermediate isolation, ensuring high purity and significant cost reduction in antibiotic manufacturing.
Advanced asymmetric synthesis of pregabalin via CN103073443B. Offers cost reduction in pharmaceutical intermediate manufacturing and reliable supply chain solutions.
Novel synthesis route avoids palladium catalysts ensuring high purity and supply chain stability for alopecia areata treatment intermediates globally
Novel Pd-catalyzed method for gamma-arylation. High yield, regioselective. Cost-effective supply chain solution for pharmaceutical manufacturing.
Novel dichloromethane-based preparation method enhances yield and purity. Reduces toxic solvent use for reliable pharmaceutical intermediate supply chain.
Patent CN103626668B reveals a novel resolution method for S-Pregabalin offering high purity and scalable supply chain advantages for pharmaceutical manufacturers.
Patent CN101519428B details a low-cost, high-purity synthesis of L-alanyl-L-glutamine using mixed anhydride activation, offering significant supply chain advantages.